Trial
NCT01489956
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Early Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Immune Tolerance Network (ITN)
Condition
Autoimmune Disorders
Intervention
Immucothel Alone (Part A)
Why stopped
Due to futility, identified after 5 subjects completed treatment in Part B
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-12